All In Biotech

Drug Trial Radar · NCT00616772

Safety and Efficacy Study Using ABT-335 (Investigational Drug) in Combination With Atorvastatin, to Study the Effects on Thickening of the Blood Vessel Wall in Patients With Abnormal Lipid (Fat) Levels in the Blood

Evaluation of Choline Fenofibrate (ABT-335) on Carotid Intima-Media Thickness (cIMT) in Subjects With Type IIb Dyslipidemia With Residual Risk in Addition to Atorvastatin Therapy (FIRST) Trial

Last checked: Nov 20, 2026Latest source record: Jul 2, 2018 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registryPivotal-lookingPhase 3. Randomized with 682 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

682

Actual

Start

Feb 2008

Primary completion

Sep 2012

Study completion Sep 2012

Sponsor

Lead sponsor
AbbVie (prior sponsor, Abbott)AbbVie (ABBV)
Sponsor type
Industry
First posted
Feb 15, 2008

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
Who can join
All sexes, from 45 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The primary purpose of this study is to test the effect and safety of once daily ABT-335 on the thickness of the lining of the carotid artery (a blood vessel to the brain) in patients with abnormal blood lipids who have optimal levels of low density lipoprotein cholesterol ("bad cholesterol") after taking atorvastatin.

Conditions

  • Coronary Artery Disease
  • Coronary Heart Disease
  • Dyslipidemia

Interventions

  • ABT-335Drug

    Capsule

  • PlaceboDrug

    Capsule

  • AtorvastatinOther

    Capsule

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Rate of Change in Mean Posterior-wall Carotid Intima-media Thickness (cIMT)Time frame: Baseline, 6 months, 12 months, 18 months, and 24 months

Locations

124 sites in 1 country. Site status is shown where the registry gives one.

  • Site Reference ID/Investigator# 6747

    Chandler, Arizona

  • Site Reference ID/Investigator# 7089

    Gilbert, Arizona

  • Site Reference ID/Investigator# 7097

    Mesa, Arizona

  • Site Reference ID/Investigator# 26394

    Phoenix, Arizona

  • Site Reference ID/Investigator# 6848

    Scottsdale, Arizona

  • Site Reference ID/Investigator# 7059

    Tempe, Arizona

  • Site Reference ID/Investigator# 7094

    Tempe, Arizona

  • Site Reference ID/Investigator# 7098

    Tempe, Arizona

  • Site Reference ID/Investigator# 25082

    Anaheim, California

  • Site Reference ID/Investigator# 21347

    Corona, California

  • Site Reference ID/Investigator# 21483

    Garden Grove, California

  • Site Reference ID/Investigator# 21351

    Huntington Beach, California

  • Site Reference ID/Investigator# 21346

    Laguna Hills, California

  • Site Reference ID/Investigator# 21341

    Long Beach, California

  • Site Reference ID/Investigator# 21342

    Norwalk, California

  • Site Reference ID/Investigator# 21321

    Santa Ana, California

  • Site Reference ID/Investigator# 26242

    Tustin, California

  • Site Reference ID/Investigator# 15283

    Arvada, Colorado

  • Site Reference ID/Investigator# 7085

    Aurora, Colorado

  • Site Reference ID/Investigator# 6749

    Denver, Colorado

  • Site Reference ID/Investigator# 7077

    Denver, Colorado

  • Site Reference ID/Investigator# 7092

    Golden, Colorado

  • Site Reference ID/Investigator# 7722

    Littleton, Colorado

  • Site Reference ID/Investigator# 7721

    Littleton, Colorado

  • Site Reference ID/Investigator# 11925

    Aventura, Florida

  • Site Reference ID/Investigator# 15861

    Boynton Beach, Florida

  • Site Reference ID/Investigator# 14422

    Deerfield Beach, Florida

  • Site Reference ID/Investigator# 19281

    Delray Beach, Florida

  • Site Reference ID/Investigator# 20881

    Hollywood, Florida

  • Site Reference ID/Investigator# 20882

    Kissimmee, Florida

  • Site Reference ID/Investigator# 19321

    Melbourne, Florida

  • Site Reference ID/Investigator# 21353

    Melbourne, Florida

  • Site Reference ID/Investigator# 18503

    Melbourne, Florida

  • Site Reference ID/Investigator# 18841

    Vero Beach, Florida

  • Site Reference ID/Investigator# 19961

    Vero Beach, Florida

  • Site Reference ID/Investigator# 7166

    West Palm Beach, Florida

  • Site Reference ID/Investigator# 6744

    West Palm Beach, Florida

  • Site Reference ID/Investigator# 19301

    Atlanta, Georgia

  • Site Reference ID/Investigator# 7051

    Atlanta, Georgia

  • Site Reference ID/Investigator# 7109

    Atlanta, Georgia

Showing 40 of 124 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.